Advertisement
Research Article| Volume 4, ISSUE 4, P787-801, December 1984

Prostaglandins In Human Disease

  • Laurence M. Demers
    Correspondence
    Corresponding author: Clinical Chemistry and Core Endocrine Laboratory, The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pennsylvania 17033
    Affiliations
    Professor of Pathology, Director, Clinical Chemistry and Core Endocrine Laboratory, The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey, Pennsylvania
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30902-8
Prostaglandins In Human Disease
Previous ArticleEctopic Hormones as Tumor Markers
Next ArticleThe Carcinoid Syndrome: Neuroendocrine and Chemical Considerations
      This paper is only available as a PDF. To read, Please Download here.
      Disturbances in prostaglandin synthesis and/or metabolism have been associated with the expression of multiple symptoms in various human disease states. Pain, fever, inflammation, and diarrhea are general symptoms among several that occur in patients who overproduce prostaglandins. Treatment of patients with prostaglandin-related symptoms in specific disease states can be achieved with prostaglandin synthesis inhibitor drugs. Plasma and urine measurements of prostaglandins can be of use in the diagnosis and monitoring of treatment of specific human diseases where prostaglandin excess is causative of the disease symptoms.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Allegra J.
        • Trautlein J.
        • Demers L.M.
        • et al.
        Peripheral plasma determinations of prostaglandin E in asthmatics.
        J. Allergy Clin. Immunol. 1976; 58: 546-550
        • Alley A.I.
        • Mauku M.S.
        • Horrobin D.F.
        • et al.
        Dipyridamole: A possible potentiate inhibitor of thromboxane A2 synthetase in vascular smooth muscle.
        Prostaglandins. 1977; 14: 607-611
        • Attallah A.A.
        • Lee J.B.
        Prostaglandins, renal function and blood pressure regulation.
        in: Lee J.B. Prostaglandins. Elsevier, New York1982: 251-282
        • Badway S.Z.
        • Marshall L.
        • Gabal A.A.
        • et al.
        The concentration of 13, 14 dihydro 15 keto PGF2α with prostaglandin E2 in peritoneal fluid of infertile patients with and without endometriosis.
        Fertil. Steril. 1982; 38: 166-170
        • Bennett A.
        Prostaglandins and Cancer.
        in: Karim S.M.M. Practical Applications of Prostaglandins and their Synthesis Inhibitors. University Park Press, Baltimore1979: 149-189
        • Blackwell G.J.
        • Carnuccio R.
        • DiRosa M.
        • et al.
        Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides.
        in: Samuelsson B. Paoletti R. Ramwell P. Advances in Prostaglandin Thromboxane and Leukotrienes Research. Vol. II. Raven Press, New York1983: 65-71
        • Bonnar J.
        Hemostasis in pregnancy and coagulation disorders.
        in: MacDonald P.R. Scientific Basis of Obstetrics and Gynecology. Churchill Livingstone, London1978
        • Borgeat P.
        • Samuelsson B.
        Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.
        J. Biol. Chem. 1979; 254: 7865-7869
        • Bygdeman M.
        • Gillespie A.
        Prostaglandins in human reproduction.
        in: Lee J.B. Prostaglandins. Elsevier, New York1982: 215-240
        • Cassin S.
        Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus of newborns.
        Semin. Perināto!. 1980; 4: 101-107
        • Cassin S.
        • Winacore I.
        • Todd M.
        • et al.
        Effect of prostacyclin on the fetal pulmonary circulation.
        Pediatr. Pharmacol. 1981; 1: 197-207
        • Chan W.Y.
        • Dawood M.Y.
        • Fuchs F.
        Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen. Effect on prostaglandin levels in menstrual fluid.
        Am. J. Obstet. Gynecol. 1979; 135: 102-109
        • Coceani F.
        Prostaglandins in the central nervous system.
        Arch Intern. Med. 1974; 133: 119-129
        • Demers L.M.
        Physiology, pharmacology, chemistry and methodology of prostaglandins.
        in: Race G. Laboratory Medicine. Vol. 1. Harper and Row, New York1978 (Chapter 23)
        • Demers L.M.
        • Brennecke S.P.
        • Mountford L.A.
        • et al.
        Development and validation of a novel radioimmunoassay for prostaglandin E2 metabolite levels.
        J. Clin. Endocrinol. Metab. 1983; 57: 101-106
        • Demers L.M.
        • Derek D.
        A radioimmunoassay for 6 keto PGF1α.
        in: Samuelsson B. Ramwell P.W. Paoletti R. Advances in Prostaglandin and Thromboxane Research. Vol 6. Raven Press, New York1980: 193-199
        • Demers L.M.
        • Gabbe S.G.
        Placental prostaglandin levels in preeclampsia.
        Am. J. Obstet. Gynecol. 1976; 126: 137-139
        • Demers L.M.
        Prostaglandins and thromboxane in haemostasis.
        Res. Clin. Forums. 1983; 5: 7-15
        • Demers L.M.
        • Allegra J.C.
        • Harvey H.A.
        • et al.
        Plasma prostaglandins in hypercalcemic patients with neoplastic disease.
        Cancer. 1977; 39: 1559-1562
        • Demers L.M.
        • Schweitzer J.
        • Lipton A.
        • et al.
        Blood 6-keto PGF1 as potential tumor marker.
        Cancer Treat. 1979; 63: 1213
        • Dusting G.J.
        • Moncada S.
        • Vane J.R.
        Prostaglandins, their intermediates and precursors, their cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.
        Prog. Cardiovasc. Dis. 1979; 21: 405-430
        • Dusting G.J.
        • Mocarda S.
        • Vane J.R.
        Prostacyclin: Its biosynthesis actions and clinical potential.
        in: Oates J.O. Prostaglandins and the Cardiovascular System. Raven Press, New York1982: 59-106
        • Ferris T.F.
        Prostaglandins, potassium and Bartter’s syndrome.
        J. Lab. Clin. Med. 1978; 92: 663-668
        • Fitzgerald G.A.
        • Sherry S.
        Pharmacology and pharmacokinetics of platelet active drugs under current clinical investigation.
        in: Oates J.A. Prostaglandins and the Cardiovascular System. Raven Press, New York1982: 107-173
        • Freidman Z.
        • Demers L.M.
        Essential fatty acids, prostaglandins and respiratory distress syndrome of the newborn.
        J. Pediatr. 1978; 61: 341-347
        • Frölich J.C.
        Methods in prostaglandin research.
        in: Advances in Prostaglandin and Thromboxane Research. Vol 5. Raven Press, New York1978
        • Goodwin J.S.
        Prostaglandins and host defense in cancer.
        Med. Clin. North Am. 1981; 65: 829-845
        • Gorman R.R.
        • Bunting S.
        • Miller O.V.
        Modulation of human platelet adenylate cyclase by prostacyclin.
        Prostaglandins. 1977; 13: 377-389

      29. Haeusler, G., and Gerold, M.: Increase in prostaglandin E like material in the canine venus blood after hydralazine or monoxadil. In Boissier, J. R.: Proceedings of the Seventh International Congress of Pharmacology, Paris, 1978, p. 806.

        • Halbert D.R.
        • Demers L.M.
        • Jones D.E.D.
        Dysmenorrhea and prostaglandins.
        Obstet. Gynecol. Surv. 1976; 31: 77-81
        • Halbert D.R.
        • Demers L.M.
        • Fontana J.
        • et al.
        Prostaglandin levels endometrial jet wash fluid in patients with dysmenorrhea before and after indomethacin therapy.
        Prostaglandins. 1975; 10: 1047-1056
        • Hamberg M.
        • Samuelsson B.
        Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.
        Proc. Natl. Acad. Sei. U.S.A. 1974; 71: 3400-3404
        • Hammarstrom S.
        Leukotrienes.
        Ann. Rev. Biochem. 1983; 52: 355-377
        • Hyman A.L.
        • Spannhake E.W.
        • Kadowitz P.J.
        Prostaglandins and the lung.
        Am. Rev. Respir. Dis. 1978; 117: 11-136
        • Hyman A.L.
        • McDay A.A.
        • Lippton H.L.
        • et al.
        Prostaglandin in the lungs.
        Med. Clin. North Am. 1981; 65: 789-808
        • Jafari E.
        • Saleem A.
        • Shaikh B.
        • et al.
        Effect of aspirin on prostaglandin synthesis by human platelets.
        Prostaglandins. 1976; 12: 829-835
        • Jaffee B.M.
        • Condon S.
        Prostaglandin E and F in endocrine diarrheagenic syndrome.
        Ann. Surg. 1976; 184: 516-524
        • Jaffee B.M.
        • Kopen D.F.
        • DeSchryver-Kecskemeti K.
        • et al.
        Pancreatic cholera and prostaglandins.
        N. Engl. J. Med. 1977; 297: 817-821
        • Jaffee B.M.
        • Santoro M.G.
        Prostaglandins and cancer.
        in: Ramwell P. Prostaglandins. Vol. 3. Raven Press, New York1977
        • Jakubowicz D.L.
        • Wood C.
        • Dewhurst S.J.
        The treatment of premenstrual tension.
        Res. Clin. Forums. 1982; 4: 119-126
        • Karim S.M.M.
        Appearance of prostaglandin F2α in human body during labor.
        Br. Med. J. 1968; 4: 618-621
        • Kot P.A.
        • Fitzpatrick T.M.
        Cardiovascular actions of prostaglandin precursors and selected prostanoic compounds.
        in: Lee J.B. Prostaglandins. Elsevier, New York1982: 177-205
        • Kurzrok R.
        • Lieb C.
        Biochemical studies of human semen. The action of semen on the human uterus.
        Proc. Soc. Exp. Biol. Med. 1930; 28: 268-272
        • Luderer J.R.
        • Demers L.M.
        • Bonnen E.M.
        • et al.
        Prostaglandins and idiopathic intestinal psuedo obstruction.
        N. Engl. J. Med. 1976; 295: 1179-1181
        • Luderer J.R.
        • Demers L.M.
        • Nomides C.T.
        • et al.
        The mechanism of action of casteroil, a biochemical link to the prostaglandins.
        in: Samuelsson B. Ramwell P.W. Paoletti R. Advances in Prostaglandin and Thromboxane Research. Vol. 8. Raven Press, New York1980: 671-676
        • Mathé A.A.
        • Hedqvist P.
        • Stranberg K.
        • et al.
        Aspects of prostaglandin function in the lung.
        N. Engl. J. Med. 1977; 296 (920–914): 850-855
        • Metz S.A.
        • McRae J.R.
        • Robertson R.P.
        Prostaglandins as mediators of paraneoplastic syndromes.
        Rev. Update Metab. 1981; 30: 299-316
        • Moncada S.
        • Vane J.R.
        The discovery of prostacyclin. A fresh insight into archidonic acid metabolism.
        in: Kharasch N. Freed J. Biochemical Aspects of Prostaglandins and Thromboxane. Academic Press, New York1977: 155-177

      49. Reese, M. C. P., Anderson, A. B. M., Turnbull, A. C., et al.: Prostaglandin levels in menstrual blood in menorrhagia and dysmenorrhea. Br. J. Obstet. Gynecol., (In press).

        • Robert A.
        • Ruwart M.J.
        Effect of prostaglandins on the digestive system.
        in: Lee J.B. Prostaglandins. Elsevier, New York1982: 113-151
        • Robertson R.P.
        Prostaglandins and hypercalcemia of malignancy.
        Med. Clin. North Am. 1981; 65: 845-855
        • Roth G.J.
        • Stanford N.
        • Majerus P.W.
        Acetylation of prostaglandin synthetase by aspirin.
        Proc. Natl. Acad. Sci. U.S.A. 1975; 72: 3073-3076
        • Samuelsson B.
        • Folco G.
        • Granstrom E.
        • et al.
        Advances in Prostaglandin and Thromboxane Research.
        Vol. 4. Raven Press, New York1978: 1-25
        • Scherbel A.L.
        Non-steroidal-antiinflammatory drugs.
        Postgrad. Med. 1978; 63: 69-74
        • Jafari E.
        • Saleem A.
        • Shaikh B.
        • et al.
        Effect of aspirin on prostaglandin synthesis by human platelets.
        Prostaglandins. 1976; 12: 829-835
        • Smith A.G.
        • Graves M.W.
        Blood prostaglandin activity associated with noradrenalin provoked flush in carcinoid syndrome.
        Br. J. Dermatol. 1974; 90: 547-551
        • Smith J.B.
        The prostanoids in haemostasis and thrombosis.
        Am. J. Pathol. 1980; 99: 743-804
        • Sors H.
        • Paradelies P.
        • Dray F.
        Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry.
        Prostaglandins. 1978; 16: 277-290
        • Toppozada M.
        Prostaglandins and their synthesis inhibitors in dysfunctional uterine bleeding.
        in: Karim S.M.M. Practical Application of Prostaglandins and Their Synthesis Inhibitors. University Park Press, Baltimore1979: 238-259
        • Tyler H.M.
        • Saxton C.A.P.D.
        • Parry M.J.
        Administration to man of UK-37, 248-01, a selective inhibitor of thromboxane synthetase.
        Lancet. 1981; 1: 629-632
        • Vane J.R.
        Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs.
        Nature (New Biol.). 1971; 231: 232-235
        • Vane J.R.
        Inhibitors of prostaglandin, prostacyclin, and thromboxane synthesis.
        in: Coceani F. Oley P.M. Advances in Prostaglandin and Thromboxane Research. Raven Press, New York1978: 27-44
        • Verstraete M.
        Thromboxane in biological systems and the possible impact of is inhibition.
        Br. J. Clin. Pharmacol. 1983; 15: 7S-11S
        • Wolfe L.S.
        • Coceani F.
        The role of prostaglandins in the central nervous system.
        Ann. Rev. Physiol. 1979; 41: 669-684
        • Zuckerman H.
        • Harpez-Kerpel S.
        Prostaglandins and their inhibitors in premature labor.
        in: Karim S.M.M. Practical Applications of Prostaglandins and Their Synthesis Inhibitors. University Park Press, Baltimore1979: 411-437
        • Zearer R.B.
        Prostaglandins and inflammation.
        in: Lee J.B. Prostaglandins. Elsevier, New York1982: 91-105

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30902-8

      Copyright

      © 1984 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX